Pelayaran Nasional Bina Buana Raya Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Pelayaran Nasional Bina Buana Raya Tbk trades at Rp114 (market cap 983.62B, 4.56M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Pelayaran Nasional Bina Buana Raya Tbk is far larger — about 3.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Pelayaran Nasional Bina Buana Raya Tbk is more actively traded (4.56M versus 159.2K). Which is the better fit depends on your goals.
| BBRM | DGNS | |
|---|---|---|
Market Cap | 983.62B | 310.75B |
Volume | 4.56M | 159.2K |
Lot | 45.59K | 1.59K |
Turnover | 515.49M | 34.72M |
Average Price | 113.08 | 218.06 |
Value | 515.49M | 34.72M |
Indicative Equilibrium Price | 114 | 220 |
Indicative Equilibrium Volume | 560 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
Pelayaran Nasional Bina Buana Raya, PT (the company) was established based on Notarial Deed No. 1 of Augi Nugroho Hartadji SH, dated February 7, 1998.
Read more on BBRM →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →